JP Morgan Chase’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $21M | Buy |
|
|||||
|
2023
Q1 | $11.2M | Sell |
|
|||||
|
2022
Q4 | $6.36M | Buy |
|
|||||
|
2022
Q3 | $3.35M | Buy |
|
|||||
|
2022
Q2 | $1.35M | Buy |
|
|||||
|
2022
Q1 | $923K | Buy |
|
|||||
|
2021
Q4 | $627K | Sell |
|
|||||
|
2021
Q3 | $2.62M | Buy |
|
|||||
|
2021
Q2 | $3.51M | Sell |
|
|||||
|
2021
Q1 | $3.7M | Sell |
|
|||||
|
2020
Q4 | $5.06M | Buy |
|
|||||
|
2020
Q3 | $3.47M | Sell |
|
|||||
|
2020
Q2 | $6.51M | Sell |
|
|||||
|
2020
Q1 | $6.08M | Sell |
|
|||||
|
2019
Q4 | $11.3M | Sell |
|
|||||
|
2019
Q3 | $4.65M | Buy |
|
|||||
|
2019
Q2 | $5.02M | Sell |
|
|||||
|
2019
Q1 | $4.92M | Sell |
|
|||||
|
2018
Q4 | $4.78M | Sell |
|
|||||
|
2018
Q3 | $10.1M | Sell |
|
|||||
|
2018
Q2 | $5.24M | Sell |
|
|||||
|
2018
Q1 | $3.46M | Sell |
|
|||||
|
2017
Q4 | $6.35M | Sell |
|
|||||
|
2017
Q3 | $7.11M | Sell |
|
|||||
|
2017
Q2 | $7.36M | Buy |
|
|||||
|
2017
Q1 | $2.96M | Sell |
|
|||||
|
2016
Q4 | $3.17M | Buy |
|
|||||
|
2016
Q3 | $3.71M | Sell |
|
|||||
|
2016
Q2 | $4.8M | Buy |
|